FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2033074637> ?p ?o ?g. }

• W2033074637 endingPage "37" @default.
• W2033074637 startingPage "29" @default.
• W2033074637 abstract "Backgrounds & Aims The N-terminally myristoylated preS1 domain of the large hepatitis B surface protein (LHBs) mediates specific attachment of hepatitis B virus (HBV) to hepatocytes. Its B-cell epitopes leading to neutralization of infectivity are not yet characterized. Methods We inserted C- and N-terminal preS1 peptides into the most immunogenic region of HBV core particles, therewith immunized Balb/c mice and determined binding properties and neutralization potential of resulting antibodies in vitro. Results The particles with preS1 inserts were highly immunogenic and the corresponding anti-preS antibodies strongly bound to HBV particles from chronic carriers infected with different HBV genotypes A–F. However, antibodies binding to the C-terminal part of preS1 did not neutralize HBV infectivity for susceptible hepatocyte cultures. In contrast, antibodies elicited by the complete N-terminal attachment site of preS1(2–48) strongly neutralized with an IC50 <3 μg/ml of total immunoglobulin. Interestingly, antibodies against the very N-terminal part of preS1(1–21) could not neutralize infectivity although this sequence contains the most conserved and essential part of the attachment site. These antibodies reacted well with non-myristoylated preS1 peptides but only weakly with myristoylated preS1 peptides, natural HBsAg or HBV. Conclusions N-terminal myristic acid obviously favors a topology of LHBs that makes the most essential part of the preS1 attachment site inaccessible for neutralizing antibodies, whereas antibodies to neighbouring sequences neutralized very well. Thus, addition of the preS1(2–48) peptide in a highly immunogenic form to the current hepatitis B vaccine may improve protective immunity and reduce selection of escape mutations. The N-terminally myristoylated preS1 domain of the large hepatitis B surface protein (LHBs) mediates specific attachment of hepatitis B virus (HBV) to hepatocytes. Its B-cell epitopes leading to neutralization of infectivity are not yet characterized. We inserted C- and N-terminal preS1 peptides into the most immunogenic region of HBV core particles, therewith immunized Balb/c mice and determined binding properties and neutralization potential of resulting antibodies in vitro. The particles with preS1 inserts were highly immunogenic and the corresponding anti-preS antibodies strongly bound to HBV particles from chronic carriers infected with different HBV genotypes A–F. However, antibodies binding to the C-terminal part of preS1 did not neutralize HBV infectivity for susceptible hepatocyte cultures. In contrast, antibodies elicited by the complete N-terminal attachment site of preS1(2–48) strongly neutralized with an IC50 <3 μg/ml of total immunoglobulin. Interestingly, antibodies against the very N-terminal part of preS1(1–21) could not neutralize infectivity although this sequence contains the most conserved and essential part of the attachment site. These antibodies reacted well with non-myristoylated preS1 peptides but only weakly with myristoylated preS1 peptides, natural HBsAg or HBV. N-terminal myristic acid obviously favors a topology of LHBs that makes the most essential part of the preS1 attachment site inaccessible for neutralizing antibodies, whereas antibodies to neighbouring sequences neutralized very well. Thus, addition of the preS1(2–48) peptide in a highly immunogenic form to the current hepatitis B vaccine may improve protective immunity and reduce selection of escape mutations." @default.
• W2033074637 created "2016-06-24" @default.
• W2033074637 creator A5005186173 @default.
• W2033074637 creator A5010967507 @default.
• W2033074637 creator A5019913804 @default.
• W2033074637 creator A5030711200 @default.
• W2033074637 creator A5043725161 @default.
• W2033074637 creator A5046499448 @default.
• W2033074637 creator A5054497262 @default.
• W2033074637 creator A5063225070 @default.
• W2033074637 creator A5065085141 @default.
• W2033074637 creator A5065462717 @default.
• W2033074637 creator A5090642835 @default.
• W2033074637 date "2011-07-01" @default.
• W2033074637 modified "2023-09-26" @default.
• W2033074637 title "N-terminal myristoylation-dependent masking of neutralizing epitopes in the preS1 attachment site of hepatitis B virus" @default.
• W2033074637 cites W1551554595 @default.
• W2033074637 cites W1579254467 @default.
• W2033074637 cites W1671075316 @default.
• W2033074637 cites W169689976 @default.
• W2033074637 cites W1751218746 @default.
• W2033074637 cites W1822042631 @default.
• W2033074637 cites W1853664782 @default.
• W2033074637 cites W1958494624 @default.
• W2033074637 cites W1966238070 @default.
• W2033074637 cites W1974093410 @default.
• W2033074637 cites W1979409884 @default.
• W2033074637 cites W1984472078 @default.
• W2033074637 cites W1988137314 @default.
• W2033074637 cites W1990646285 @default.
• W2033074637 cites W1990677566 @default.
• W2033074637 cites W1996547056 @default.
• W2033074637 cites W2003989022 @default.
• W2033074637 cites W2006899228 @default.
• W2033074637 cites W2011222991 @default.
• W2033074637 cites W2018143218 @default.
• W2033074637 cites W2020757435 @default.
• W2033074637 cites W2022257442 @default.
• W2033074637 cites W2024094503 @default.
• W2033074637 cites W2025047212 @default.
• W2033074637 cites W2025810603 @default.
• W2033074637 cites W2027063509 @default.
• W2033074637 cites W2033712814 @default.
• W2033074637 cites W2033867130 @default.
• W2033074637 cites W2036298444 @default.
• W2033074637 cites W2037165222 @default.
• W2033074637 cites W2038046083 @default.
• W2033074637 cites W2038144993 @default.
• W2033074637 cites W2046848640 @default.
• W2033074637 cites W2046898131 @default.
• W2033074637 cites W2048790396 @default.
• W2033074637 cites W2052100442 @default.
• W2033074637 cites W2055713619 @default.
• W2033074637 cites W2061560671 @default.
• W2033074637 cites W2061594530 @default.
• W2033074637 cites W2061734833 @default.
• W2033074637 cites W2063721965 @default.
• W2033074637 cites W2075464836 @default.
• W2033074637 cites W2082821380 @default.
• W2033074637 cites W2085841644 @default.
• W2033074637 cites W2088472124 @default.
• W2033074637 cites W2089670256 @default.
• W2033074637 cites W2093122269 @default.
• W2033074637 cites W2103776714 @default.
• W2033074637 cites W2107983386 @default.
• W2033074637 cites W2114283220 @default.
• W2033074637 cites W2117756276 @default.
• W2033074637 cites W2122440054 @default.
• W2033074637 cites W2138191292 @default.
• W2033074637 cites W2141248681 @default.
• W2033074637 cites W2147058388 @default.
• W2033074637 cites W2159712152 @default.
• W2033074637 cites W2160302934 @default.
• W2033074637 cites W2169220663 @default.
• W2033074637 cites W4322578578 @default.
• W2033074637 doi "https://doi.org/10.1016/j.jhep.2010.10.019" @default.
• W2033074637 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21145866" @default.
• W2033074637 hasPublicationYear "2011" @default.
• W2033074637 type Work @default.
• W2033074637 sameAs 2033074637 @default.
• W2033074637 citedByCount "52" @default.
• W2033074637 countsByYear W20330746372012 @default.
• W2033074637 countsByYear W20330746372013 @default.
• W2033074637 countsByYear W20330746372014 @default.
• W2033074637 countsByYear W20330746372015 @default.
• W2033074637 countsByYear W20330746372016 @default.
• W2033074637 countsByYear W20330746372017 @default.
• W2033074637 countsByYear W20330746372018 @default.
• W2033074637 countsByYear W20330746372019 @default.
• W2033074637 countsByYear W20330746372020 @default.
• W2033074637 countsByYear W20330746372021 @default.
• W2033074637 countsByYear W20330746372022 @default.
• W2033074637 countsByYear W20330746372023 @default.
• W2033074637 crossrefType "journal-article" @default.
• W2033074637 hasAuthorship W2033074637A5005186173 @default.
• W2033074637 hasAuthorship W2033074637A5010967507 @default.
• W2033074637 hasAuthorship W2033074637A5019913804 @default.
• W2033074637 hasAuthorship W2033074637A5030711200 @default.

• next